To investigate the underlying mechanism through which RIG-I regulates the biological characteristics of melanoma cells, we analyzed the effects of RIG-I on the modulation of the ERK, AKT and p38 MAPK pathways, which have been demonstrated to be critical regulators in the proliferation and apoptosis of cancer cells. The gene discussed is AKT1; the disease is cancer.